Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Gencia and Takeda to discover and develop mitochondrial therapeutic compounds

Sep. 15, 2015

No Comments

FDA accepts first NDA for a digital medicine

Sep. 14, 2015

No Comments

Phase I findings confirm bioavailability of Gordagen's MELT3 formulation

Sep. 14, 2015

No Comments

Novo Nordisk and MIT to explore next generation of drug delivery devices

Sep. 10, 2015

No Comments

European ADAPT SMART initiative launched to improve efficiency in drug development

Sep. 8, 2015

No Comments

AstraZeneca licenses Starpharma's dendrimer-based drug delivery technology

Sep. 8, 2015

No Comments

Wistar Institute and Spark Therapeutics to study liver-directed gene therapy vectors

Sep. 8, 2015

No Comments

Novimmune and Baxalta form collaboration to discover bispecific antibodies

Sep. 7, 2015

No Comments

Ex scientia delivers first compound in Sumitomo Dainippon collaboration

Sep. 7, 2015

No Comments

Essex Bio-Technology and Tasly Pharmaceutical collaborate on recombinant protein drugs

Sep. 3, 2015

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Gencia and Takeda to discover and develop mitochondrial therapeutic compounds

FDA accepts first NDA for a digital medicine

Phase I findings confirm bioavailability of Gordagen's MELT3 formulation

Novo Nordisk and MIT to explore next generation of drug delivery devices

European ADAPT SMART initiative launched to improve efficiency in drug development

AstraZeneca licenses Starpharma's dendrimer-based drug delivery technology

Wistar Institute and Spark Therapeutics to study liver-directed gene therapy vectors

Novimmune and Baxalta form collaboration to discover bispecific antibodies

Ex scientia delivers first compound in Sumitomo Dainippon collaboration

Essex Bio-Technology and Tasly Pharmaceutical collaborate on recombinant protein drugs

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS